Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Oral Evidence - Lord Norman Fowler continued - London - 22/09/2021

Published on: 29 September, 2021

Oral Evidence - Presentation by Counsel to the Inquiry relating to pharmaceutical companies involved in blood products: Hyland, Travenol and Immuno - 24/09/2021

Published on: 02 May, 2023

Oral Evidence - Presentations on the licensing of blood products and pharmaceutical companies involved in blood products: Hyland, Travenol and Immuno - 23/09/2021

Published on: 11 May, 2023

Oral Evidence - Lord Norman Fowler - London - 21/09/2021

Published on: 29 September, 2021

Oral Evidence - Presentation by Counsel to the Inquiry relating to knowledge of and response to risk by pharmaceutical companies involved in blood products - London - 2/11/2021

Published on: 02 May, 2023

Oral Evidence - Presentation by Counsel to the Inquiry relating to pharmaceutical companies involved in blood products: Speywood; Sarah Middleton) - London - 1/10/2021

Published on: 02 May, 2023

Oral Evidence - Presentation by Counsel to the Inquiry about smaller haemophilia centres: East Anglia, North Wales and other English centres - London - 7/10/2021

Published on: 11 May, 2023

Oral Evidence - Presentation by Counsel to the Inquiry about smaller haemophilia centres: other English centres - London - 8/11/2021

Published on: 11 May, 2023

Oral Evidence - Presentation by Counsel to the Inquiry relating to pharmaceutical companies involved in blood products: Alpha, Abbott and Grifols & about smaller haemophilia centres - London - 6/10/2021

Published on: 15 November, 2021

Oral Evidence - Presentation by Counsel to the Inquiry about Professor John Cash (deceased) - London - 10/11/2021

Published on: 02 May, 2023

Oral Evidence - Presentations by Counsel to the Inquiry relating to the organisation and history of the blood services - London - 9/11/2021

Published on: 27 April, 2023

Oral Evidence - Christopher Bishop - London - 4/11/2021

Published on: 15 November, 2021

Oral Evidence - Presentation by Counsel to the Inquiry relating to knowledge of and response to risk by pharmaceutical companies involved in blood products (Continued) - London - 3/11/2021

Published on: 02 May, 2023

Oral Evidence - Presentations by Counsel to the Inquiry about the work of Professor John Cash (continued) and the work of Dr Harold Gunson (deceased))- London - 11/11/2021

Published on: 28 April, 2023

TSTC0000047 - Blood tissue and organ screening HC 990 - 30 Apr 2014

Published on: 24 April, 2024

TSTC0000049 - Blood tissue and organ screening HC 990 - 26 Mar 2014

Published on: 24 April, 2024

Oral Evidence - Presentation by Counsel to the Inquiry about the work of Dr Harold Gunson (continued) - London - 12/11/2021

Published on: 28 April, 2023

Oral Evidence - Presentation by Counsel to the Inquiry relating to pharmaceutical companies involved in blood products: Armour and Bayer - London - 29/9/2021

Published on: 11 May, 2023

Oral Evidence - Presentation by Counsel to the Inquiry relating to pharmaceutical companies involved in blood products: Travenol and Armour - London - 28/9/2021

Published on: 28 April, 2023

Oral Evidence - Presentation by Counsel to the Inquiry relating to pharmaceutical companies involved in blood products: Bayer - London - 30/9/2021

Published on: 28 April, 2023

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2799
  • Page 2800
  • Page 2801
  • Page 2802
  • Current page 2803
  • Page 2804
  • Page 2805
  • Page 2806
  • Page 2807
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.